In addition to TERT, we found rare non-synonymous variants in three genes associated with decreased prostate cancer risk (ANO7, SPDL1 and AR), and three genes associated with increased risk (HOXB13, CHEK2 and BIK). This evidence concerns the gene CHEK2 and Familial prostate cancer.